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Abstract 
Objective: The objective was to compare the postprandial glycemic and 
insulinemic responses to nutrition bars containing either cross-linked RS type 4 (RS4XL) 
or standard wheat starch in normoglycemic adults (n=13; age= 27±5 yr; BMI=25±3 
kg/m2). 
Methods: Volunteers completed three trials during which they consumed a 
glucose beverage (GLU), a puffed wheat control bar (PWB), and a bar containing RS4XL 
matched for available carbohydrate content.  Serial blood samples were collected over 
two hours and glucose and insulin concentrations were determined and the incremental 
area under the curve (iAUC) was calculated.   
Results: The RS4XL peak glucose and insulin concentrations were lower than the 
GLU and PWB (p<0.05).  The iAUC for glucose and insulin were lower following 
ingestion of RS4XL compared with the GLU and PWB trials.   
Conclusions: These data illustrate, for the first time, that directly substituting 
standard starch with RS4XL, while matched for available carbohydrates, attenuated 
postprandial glucose and insulin levels in humans.   It remains to be determined 
whether this response was due to the dietary fiber and/or resistant starch aspects of the 
RS4XL bar. 
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INTRODUCTION 
Consumption of whole grains has been recommended to improve insulin 
sensitivity and lower serum glucose and insulin concentrations. Whole grain 
consumption of three servings or more per day was among changes that were included 
in the 2005 dietary guidelines to reduce the risk of acquiring chronic diseases [1]. Whole 
grains are major sources of dietary fiber (DF), yet typical DF consumption patterns do 
not meet the recommended 25-35g per day.  Therefore, eating more grain-based fiber-
rich foods is warranted to help optimize health and potentially manage some chronic 
metabolic conditions. 
At present, resistant starches (RS) have drawn broad interest for their health 
benefits and functional properties [2; 3]. Initial clinical studies demonstrated that RS has 
properties similar to soluble fiber, shows promising physiological benefits in humans, 
and may prevent disease.  Several potential physiological benefits ascribed to RS 
include: attenuation of blood glucose and insulin levels in both healthy and diabetic 
individuals, positive effects on large bowel health and prevention of colonic cancer, 
increased absorption of minerals, serving as a prebiotic, and increased fat oxidation [3-
9].  There are four basic “types” of RS.  Type 1 is composed of starch granules 
embedded in a dense protein matrix and found in legumes.  Type 2 (RS2) is a 
combination of RS granules and high amylose starch as is found in green bananas and 
high amylose maize.  Type 3 (RS3) is retrograded starch that occurs via alterations in 
the cooking/cooling process of starchy foods.  Type 4 (RS4) is a chemically modified 
starch typically through esterification or cross-linking (RS4XL).   
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The majority of human clinical trials have been conducted using only RS2 or 
RS3, which tend to illustrate decreased blood glucose following consumption of foods 
with these starches added  [3; 6; 10-15].  It is difficult to fully understand the beneficial 
capacity of RS due to the methods used in the human clinical trials that tested the 
efficacy of RS.  For example, one clinical trial failed to control both the amount and 
source of all the ingredients [16].  In a study investigating the effects of esterified RS 
type 4 (RS4OSA), Heacock et al [17] reported that RS4OSA decreased peak glucose and 
insulin levels when it was administered in water, but RS is typically consumed in foods.  
Also, in studies by Behall et al. [18; 19],  the amount of available carbohydrate differed, 
which limits the capacity to determine if the attenuation of glucose and insulin was due 
to the RS or the fact there was less available carbohydrate.  Furthermore, Robertson et 
al. [6] provided packets containing RS2 for volunteers to sprinkle on their food thereby 
not illustrating the effects that might be achieved when provided in the food supply.  
Taken together, the available data illustrate that RS has the potential to lower blood 
glucose.  However, few clinical trials testing the effects of RS have controlled 
ingredients and the amount of available carbohydrates to better delineate the role of RS 
in affecting the insulin and glucose responses, and no published clinical trials 
investigating the glucose lowering potential of RS4XL exist.   
Therefore, the aim of this study was to investigate the acute effects of consuming 
RS4XL incorporated into a nutrition bar, while controlling for non-starch ingredients and 
available carbohydrates, on postprandial glucose and insulin responses in young adults 
with a randomized clinical trial (NCT00687960, clinicaltrials.gov). 
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Materials and Methods 
Subjects 
The Institutional Review Board of Kansas State University approved the study, and 
written informed consent was obtained from all volunteers prior of the study.  Inclusion 
criteria were no diagnosis of acute or chronic metabolic diseases, free of 
gastrointestinal disorders, body mass index of 23-30 kg/m2, and non-smokers.  
Volunteers were screened for glucose tolerance using a two hour 75 g glucose 
tolerance test prior to participation.  Eighteen healthy younger adults were recruited and 
13 participated in and completed the study, while the other five did not meet the criteria.  
Of the 13 volunteers (age=27±5 y, BMI=25±3 kg/m2, HOMA=0.94±0.34) seven were 
females and six were males.  Based on BMI values, these volunteers all have similar 
risks for all-cause and obesity-related mortality [20].  Also, an oral glucose tolerance test 
was performed prior to enrollment to ensure each volunteer had normal glucose 
tolerance.  
 
Oral Glucose Tolerance Test 
Prior to enrollment, volunteers arrived after a 12 hour overnight fast.  Blood samples 
were drawn by finger stick at baseline and 120 min after ingesting 75g of glucose in 
solution (296 ml; Sun-Dex 75g, Fisher Scientific, Houston, TX).  Samples were analyzed 
in duplicate for glucose concentration (YSI 2300 STAT, Yellow Springs, OH).  The oral 
glucose tolerance test was used to confirm the absence of pre-diabetes or diabetes. 
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Study Design 
All trials were performed at the Human Metabolism Laboratory at Kansas State 
University.  Volunteers completed three trials via a controlled randomized crossover 
design.  During each trial, volunteers consumed one of the following: dextrose solution 
(198 ml of a standard 75 g oral glucose tolerance beverage; GLU), a control bar 
containing puffed wheat (65 g; PWB), and a bar containing cross-linked RS4XL bar (80g; 
RS4XL) (Table 1).  All treatments were designed to provide 50 g of available 
carbohydrate (Table 2).  All trials were completed by each volunteer with at least a 
seven day washout between testing days.  This was a quasi-blinded experiment in that 
one treatment was a beverage and the other two were in bar form, which were randomly 
administered using a Latin Square design.  Some female volunteers did not use oral 
contraceptives, but others used either contraceptive pills or progesterone injections.  
Regardless, the females were scheduled to perform all the trials during the follicular 
phase of their menstrual cycle and each served as their own control.   
 
Experimental Bars 
The only altered ingredients between bars were either puffed wheat or RS4XL (Table 1). 
Briefly, the nutrition bars were prepared by adding puffed wheat or cross-linked RS4 to 
wheat germ.  The dose of the RS4XL (27.2 g)  was intended to be close to the dose 
used previously [6], whereby a significant improvement in insulin sensitivity was 
observed.  The remaining ingredients (water, corn syrup, brown sugar, gum acacia, and 
Panodan 150K) were heated to 85°C over 4 min, poured over the dry ingredients, and 
then manually mixed quickly until dry ingredients were evenly distributed throughout the 
mixture.  The mixture was scooped into a metal pan, pressed evenly throughout the 
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pan, and allowed to cool for 20 min before cutting into bars.  Crude nutrient analysis 
was determined by proximate analysis, while total dietary fiber was assessed 
independently (Medallion Labs, Minneapolis, MN) (Table 2).  Available carbohydrate 
was calculated as the difference between total carbohydrate and dietary fiber as used 
previously [9].  Controlling for available carbohydrate in this fashion has been shown to 
affect the glycemic response, while controlling for RS content does not significantly 
affect the glycemic response [21]. 
 
Food Tolerance Test:   
The postprandial test (two-hours with seven blood samples) was modified from 
Flammang et al. [22].  During each test, volunteers arrived to the laboratory after a 10-
12 hour overnight fast.  An indwelling catheter (Terumo®, 22gx1”, Terumo Medical 
Corporation, Elekton, MD) was inserted into a forearm vein.  The line was kept patent 
with 0.9% isotonic saline solution (0.9% sodium chloride USP, B. Braun Medical Inc., 
Irvine, CA).  Ten minutes after inserting the i.v. catheter, the fasting blood sample was 
collected.  Thereafter, the volunteers consumed the assigned food item for that day.  
The solution (GLU) or bar was consumed within 10 min.  The treatment bars were 
served with 198 ml of water (to match the fluid that was consumed during the GLU trial).  
Relative to taking the first bite of food, blood samples were collected at -10, 10, 20, 30, 
60, 90, and 120 minutes. 
 
Blood Samples 
After collection, blood samples were centrifuged at 2,500 rpm for 15 min at 4ºC.  The 
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plasma was extracted from the vacutainer and immediately analyzed in duplicate for 
glucose (YSI 2300, Yellow Springs Instruments, Yellow Springs, OH) with the remainder 
stored at -80ºC.  The frozen samples were analyzed in duplicate for insulin using an 
endocrine assay (LINCOplex kit, St. Charles, MO), and measured by Luminex100® 
(Austin, TX) instrumentation.  Once the samples were analyzed, the highest value 
attained over the 120 minutes was determined to be the peak value, with the difference 
between baseline and peak determined to measure the change from fasting to peak. 
 Glucose and insulin areas under the curve (iAUC) were determined using the 
trapezoid method (GraphPad Prism v 5.02, La Jolla, CA). This approach was adapted 
from a previous RS feeding study [18].  Fasting insulin and glucose values were also 
used to calculate the homeostasis model assessment (HOMA) [23]. 
 
Diet and Physical Activity Records 
A diet record was completed by the volunteers prior the first test of the study.  
Volunteers were instructed on how to record their intakes.  They were requested to then 
eat the same foods from that diet record the day before the second and third trials.  This 
procedure was used previously [24].  Also, volunteers were requested to record their 
physical activity for the day before testing and perform that same activity (or inactivity) 
the day prior to the subsequent tests.   
 
Data Analysis 
Sample size estimation was calculated using PASS software (NCSS 2007 and PASS 
2005, Kaysville, UT). Based on results from previously published data using RS2 [6], six 
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volunteers were determined necessary (power>0.80, and p<0.05) to detect significant 
differences in glucose and insulin responses.  A repeated measures analysis of 
variance (SPSS version 11.5, Chicago, IL) was used to determine significant main 
effects with significance set at p= 0.05.  Paired t-tests (SPSS version 11.5, Chicago, IL) 
were used to determine differences between and among trials for peak, change from 
baseline to peak and iAUC values for glucose and insulin.  The comparisons of interest 
were primarily between the two bars, with the glucose treatment providing a standard 
point of reference. 
 
Results 
The three meals provided practically the same amount (50-51g) of available 
carbohydrate (Table 2). Both nutrition bars contained similar amounts of protein and 
were low in fat, but the RS4XL bar contained four times the dietary fiber (20g vs 5g) 
compared to the PWB.  Approximately one-fifth of the total dietary fiber in the RS4XL bar 
was from gum arabic (~4.4 g) with the remainder (~15.6g) being from RS4XL.  The 
meals differed in their calculated food-energy contents (200-326 kcal, Table 2) because 
their compositions differed and because their weights to deliver 50g of available 
carbohydrates differed. 
 The commercially available RS4XL used in this study contains 0.4% phosphors, 
10.6% moisture, 91.9% total dietary fiber by AOAC-International Method 991.43, and 
83.3% RS by a modified Englyst method [25].  At the time of preparing the 80g bar of 
RS4XL, the amount of RS added was ~ 20g (dry solids) according to the formula in 
Table 1 and the composition of Fibersym RW, while the amount of gum arabic added 
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was 4.4 g (dry solids).  At the time of analyzing the finished 80g bar, the bar contained 
20g of total dietary fiber (Table 2).  Assuming no loss of gum arabic in the preparation of 
the RS4XL bar, the 4.4 g loss of dietary fiber could be attributed to some damage to the 
RS, which increased its digestibility.  Assuming the ratio of RS to dietary fiber remains 
constant at 0.9 in partially damaged RS4XL,  then the 80g bar of RS4XL fed to the 
subjects contained ~ 14g  RS, implying ~70% was maintained following preparation of 
the bar. 
 The RS4 bar elicited decreased glucose and insulin concentrations at several 
time points (Fig 1) during the 120 minute postprandial period as compared with GLU 
and PWB.  Also, consumption of the RS4 bar led to an attenuation of peak glucose and 
insulin, and significant differences from baseline to peak and iAUC values for glucose 
and insulin when compared with GLU and PWB (Table 3).  The PWB bar attenuated the 
peak glucose and insulin responses and the iAUC for glucose and insulin compared 
with GLU.  The percent increase from baseline to peak was not different (p=0.068) from 
GLU for glucose, while it was for insulin. 
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 Discussion 
 These data, for the first time, indicate that eating RS4XL from wheat in place of 
standard wheat starch significantly decreased postprandial insulin and glucose 
responses.  These results are in line with others investigating the insulin and/or glucose 
lowering effects when RS (typically RS2) is added to foods or incorporated in the diet [6; 
16; 18; 26; 27], while a few reported no effect of RS2 or RS3 on glycemia [7; 9].  
Results from several other clinical trials reported RS decreased the glycemic response, 
but those studies either had volunteers sprinkle RS onto the food instead of it being an 
ingredient in the food, mixed only with water, ate large (up to 388 g) portion sizes, failed 
to control for available carbohydrate, and/or the food eaten contained different 
ingredients with varying amounts of available carbohydrate [6; 16; 18; 26; 27]. 
 One of the more surprising outcomes was that RS4XL significantly attenuated the 
glycemic and insulinemic responses even when high glycemic ingredients were eaten.  
This observation is critical for consumers and food scientists when looking for or 
creating foods to control blood glucose levels in that they may not need to avoid foods 
containing corn syrup or sugar for the purpose of regulating their blood glucose levels.  
That is, these data clearly indicate that even though two foods contain identical 
concentrations of glycemic ingredients, the presence of RS4XL may significantly lower 
glucose and insulin responses.  In the case of the bars that were tested, the volunteers 
actually consumed more corn syrup and brown sugar in the RS4XL bar since they 
consumed 15 g more of that bar than the PWB bar. Yet, the glycemic and insulinemic 
responses for the RS4XL bar were significantly attenuated compared with the PWB bar 
that was matched for available carbohydrate yet contained less (by weight) sugar and 
10 
 
corn syrup (Table 3).  This does not imply that eating sugar and corn syrup is healthy, 
but that foods high in RS4XL attenuate glycemia and insulinemia compared with those 
with standard whole wheat starch when sugar and corn syrup are present and account 
for ~30% of the energy.  This is of interest as sugar and corn syrup have been the target 
of criticism for potentially contributing to the obesity and diabetes epidemics [28-30].   
 The observed attenuation of the glucose and insulin responses might be a result 
of high concentrations of DF and/or RS in the RS4XL bar.  In separate in vitro analyses 
for DF and RS, this version of cross-linked RS4 has been shown to contain 91.9% 
dietary fiber and 83% resistant starch [25].  Relative to clinical trials that used RS2, Le 
Leu et al [31] recently reported that several varieties of RS2 only contain 18-60% dietary 
fiber and 46-53% RS.  Thus, this cross-linked form of RS4 likely elicited the significant 
difference due to a relatively high content of fiber and RS. 
 This study is not without limitations.  While we did observe a significant 
attenuation in glucose and insulin responses when RS4XL was incorporated into the bar, 
it is not possible to know whether the same effects would occur in individuals with 
insulin resistance or other metabolic conditions.  It could be suggested that the current 
dose used for the RS4XL bar (80 g) might be greater than one would choose to consume 
at one sitting.  A more realistic approach might be to base the doses on average serving 
sizes, but that would only offer 15-20 g of available carbohydrate in the RS4XL bar.  That 
said, a previous study [26] had volunteers consume treatment foods that were nearly 
five-fold greater.  Likewise, we were trying to match the amount of available 
carbohydrate at 50 g, which is recommended for glycemic index testing [32].  Another 
potential confounding issue, especially when comparing the bars with the solution, is the 
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difference in gastric emptying [33].  Also, the total energy contained within the RS4XL 
bar did not take into account the energy provided via fermentation of the RSXL into short 
chain fatty acids.  Lastly, we cannot determine the mechanism for the effect observed.   
It is reasonable to conclude that the RS4XL caused the effects, as it was the only 
ingredient difference, but it is not possible to determine how much of the change was 
attributable to the dietary fiber or the RS that is contained within RS4XL. 
 In conclusion, this is the first published randomized clinical trial to investigate the 
glucose and insulin lowering potential of RS4XL.  Additionally, this is one of a few clinical 
studies where the treatments were matched for available carbohydrate and the RS was 
substituted directly for standard starch in the tested food, while all other ingredients 
were identical.  This ingredient and nutrient control minimizes confounding factors that 
are present when treatments are matched instead for total carbohydrate [18] or when 
different ingredients are used in clinical trials [16].  While it is unknown what component 
(dietary fiber or resistant starch) of RS4XL lowered glucose and insulin, it is clear that 
RS4XL was responsible for the observed differences between bars.    
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DF = dietary fiber 
GLU = glucose control solution 
iAUC = incremental area under the curve 
HOMA = Homeostasis Model Assessment of insulin sensitivity 
PWB = control bar made with puffed wheat 
RS = resistant starch 
RS4XL = treatment bar made with cross-linked resistant starch type 4
13 
 
Table 1. Ingredients and their concentrations by relative weight (% total) in the test 
bars. 
 
      PWB  RS4XL 
Puffed Wheata    34  -- 
Resistant Starch type 4b   --  34 
Corn Syrupc     20  20 
Wheat Germd    18  18 
Brown Sugar e    11  11 
Waterf      10  10 
Gum Acaciag     6  6 
Panodan 150Kh    1  1 
a=Quaker Oats 
b=Fibersym RW; MGP Ingredients, Inc. 
c=Karo light corn syrup 
d=Kretschmer® Original Toasted 
e=C&H Pure Cane Sugar, golden brown 
f=Tap water (Manhattan, KS) 
g=TIC Gums  
h=Danisco  
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Table 2.  Nutrient composition of each treatment per dose (GLU = 198 ml; PWB = 65 g; 
RS4 = 80g). 
     GLUa  PWBb  RS4XLb____!e 
Total Energy (kcal)   200  261  326 (65 kcal,125%) 
Carbohydrate (g) 
 Total    50  56  71 (15 g, 127%) 
 Availablec   50  51  51 (0 g, 0 %) 
Total Dietary Fiber (g)d  --  5  20 (15 g, 400%) 
Fat (g)     --  1  2 (1 g, 200%) 
Protein (g)    --  7  6 (1 g, 86%) 
a= glucose tolerance test beverage (Sun-Dex, Fisher Scientific, Houston, TX) 
b=Crude nutrient composition was determined by proximate analysis (total energy, total 
fat, total protein, total carbohydrate).  
c=derived by subtracting total dietary fiber from total carbohydrate. 
d=dietary fiber analysis was performed by Medallion Laboratory (Minneapolis, MN). 
e=difference (subtraction value, % value) between bars
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Table 3.  Values for the incremental areas under the curves of glucose and insulin 
concentrations during each trial. 
 
    GLUC   PWB   RS4XL 
Glucose 
iAUC (mmol/L • 2 hr) 140±31A  84±17B  28±11C 
Peak  (mmol/L)  7.30±0.5A  6.33±0.3B  5.40±0.2C 
Increase (%)   60.5±10A  42.7±6A  20.4±3B  
 
Insulin 
iAUC (pM • 2 hr)  17,575±2,236A 8,758±1,132B 3,659±974C 
Peak (pM)   344±36.7A  211.5±20.1B  162.3±22.6C 
Increase (%)   335±53.2A  243.0±49.3B  126.3±45.8C 
Mean±SE; different letters within a row indicates significant difference (P<0.05). 
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